American Trust Cuts Stake in The Procter & Gamble Company (NYSE:PG)

American Trust reduced its position in shares of The Procter & Gamble Company (NYSE:PG - Free Report) by 10.9% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 25,926 shares of the company's stock after selling 3,184 shares during the quarter. American Trust's holdings in Procter & Gamble were worth $4,490,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Acorn Creek Capital LLC lifted its holdings in shares of Procter & Gamble by 2.8% during the third quarter. Acorn Creek Capital LLC now owns 2,170 shares of the company's stock worth $376,000 after purchasing an additional 59 shares during the period. Patrick M Sweeney & Associates Inc. lifted its holdings in shares of Procter & Gamble by 1.1% during the third quarter. Patrick M Sweeney & Associates Inc. now owns 5,561 shares of the company's stock worth $963,000 after purchasing an additional 59 shares during the period. Hudson Value Partners LLC lifted its holdings in shares of Procter & Gamble by 4.1% during the second quarter. Hudson Value Partners LLC now owns 1,516 shares of the company's stock worth $250,000 after purchasing an additional 60 shares during the period. Traveka Wealth LLC raised its stake in Procter & Gamble by 1.7% during the third quarter. Traveka Wealth LLC now owns 3,554 shares of the company's stock worth $616,000 after buying an additional 60 shares during the last quarter. Finally, Allen Mooney & Barnes Investment Advisors LLC raised its stake in Procter & Gamble by 0.7% during the third quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 8,699 shares of the company's stock worth $1,507,000 after buying an additional 61 shares during the last quarter. 65.77% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. DZ Bank raised shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $190.00 target price for the company in a research note on Thursday, August 29th. Piper Sandler started coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They set a "neutral" rating and a $174.00 target price for the company. Evercore ISI lifted their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an "outperform" rating in a research note on Monday, October 21st. Wolfe Research raised shares of Procter & Gamble to a "strong-buy" rating in a research note on Friday, August 23rd. Finally, Barclays downgraded shares of Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 price target for the company. in a research note on Monday, September 30th. Eight research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Procter & Gamble currently has an average rating of "Moderate Buy" and an average target price of $180.45.

Insider Buying and Selling

In other news, insider Susan Street Whaley sold 634 shares of the stock in a transaction on Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $108,826.10. Following the transaction, the insider now owns 19,341 shares of the company's stock, valued at $3,319,882.65. This represents a 3.17 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. The trade was a 54.48 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 83,080 shares of company stock valued at $14,629,038. Company insiders own 0.18% of the company's stock.

Procter & Gamble Stock Performance

PG traded up $0.21 during midday trading on Friday, reaching $171.06. The company had a trading volume of 3,862,181 shares, compared to its average volume of 6,686,880. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock has a market cap of $402.85 billion, a PE ratio of 29.44, a P/E/G ratio of 3.69 and a beta of 0.44. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $180.43. The business has a 50-day moving average price of $170.69 and a two-hundred day moving average price of $169.51.

Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same quarter in the previous year, the firm posted $1.83 earnings per share. The company's quarterly revenue was down .6% compared to the same quarter last year. On average, sell-side analysts expect that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.35%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble's dividend payout ratio (DPR) is presently 69.48%.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.